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The broad spectrum of biological activity associated with steroids 
makes them a very intriguing class of compounds. In recent years much 
attention has been focused on the biological activities of steroids 
possessing nitrogen atoms (Alauddin and Martin-Smith, 1962a,b). The 
azasteroid class of compounds possess several desirable physical char-
acteristics which make them useful as tools for elucidating the 
mechanisms of biological phenomenon: (1) a high degree of fluorescence; 
(2) increaseo water solubility at physiological pH; (3) hydrogen 
bonding potential; and, (4) the potential for molecular complex 
formation. 
The nitrogenous steroids possess many pharmacological properties 
which make them suitable for use as therapeutic agents. The most 
notable of these properties are anti-inflammatory activity, anti-
hypercholesterolaemic activity, digitalis-like activity, coronary 
dilatory activity and central nervous system activity. Several new 
azasteroid compounds have also been prepared that show weak androgenic, 
estrogenic and progestational activity. Several nitrogen containing 
steroids have been shown to possess anti-tumor activity, and the 
numbers of azasteroids shown to have antibacterial properties has also 
increased in recent years (Martin-Smith and Sugrue, 1964). Svoboda, 
Thompson and Robbins (1972) recently reported an interesting use of 
1 
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azasteroid compounds as inhibitors of insect molting and metamorphosis. 
Barnett, Ryman and Smith (1946~) were the first to report anti-
bacterial activity of azasteroid compounds and found that both the o<. 
and s isomers of 7-aminocholesterol showed a high antibacterial 
activity in vitro against gram-positive organisms. These authors - ,. . . ' 
also reported that mono- and di-cholestane derivatives with nitrogen 
in the 3, 6 or 7 positions showed marked antimicrobial activity; 
however, only the diaminosteroids showed any apprecial:>le bacteriostatic 
activity against gram-negative organisms, Both mono- and diamino-
s teroi ds were highly active jn vitro against Strep,t~cocci and 
Staphylococci; however, the diaminosteroids consistently showed a 
higher antibacterial potency than the monoqJninosteroids. Moreover, 
the 3:6, 3:7 and 6:7-diaJTiinosteroids showed considerable bacteriostatic 
activity against gram~negative organisms, whereas, the rnonoamino-
steroids showed activity only against gram-positive organisms (Barnett, 
Ryman and Smith, 1946b), 
Kull, Castellano and Mayer (1953) and Tarbet, Dura and Sternberg 
) 
(1953) also reported that certain steroids containing nitrogen in the 
form of amino groups attached to the steroid nucleus were effective 
against microorganisms. However, Smith, Shay and Doorenbos (1963a) 
were the first to report a group of steroids containing nitrogen in 
the nucleus that showed antimicrobial properties. Doorenbos and 
Bossle (1965) reported that derivatives of 4-aza-5o<.-cholestane were 
bacteriocidal against most gram-positive bacteria and fungicidal 
against most molds and yeasts. 
The results of this work were in agreement with that of Lester 
and Hechter (1958) and Casas-Campillo et al. (1961), who found that 
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sensitivity to steroids was limited essentially to gram-positive 
microorganisms. The gram-positive bacteria were the most sensitive 
while the yeasts and molds were the least sensitive. With the 
exception of Brucella abortus, none of the gram-negative bacteria 
showed any sensitivity to the steroids. Although none of the steroids 
inhibited the gram-negative bacteria, the sixteen compounds tested by 
Smith, et al. (1963a) interfered with the production of the lipid-
soluble pigment of Serratia marcescens. The water-soluble pigment of 
Pseudomonas aeruginosa was readily synthesized in the presence of the 
steroids. 
Smith, Shay and Doorenbos (1963b) were among the first to devote 
attention to the mechanism of action of azasteroid compounds which do 
not occur in nature. Working with nitrogen-substituted cholestanes, 
they observed spontaneous hemolysis of sheep and human red blood cells, 
These same authors later reported (1964) that none of the biologically 
active azasteroid compounds caused complete disruption of sheep red 
blood cells. Azasteroid action caused marked extrusion of hemoglobin; 
however approximately 50 percent of the cells were still intact after 
16 hours. A positive relationship between antimicrobial activity and 
hemolytic activity was not found; however, these authors postulated 
that the lethal effects of these azasteroids may be assisted by the 
surfactant properties. 
Further work on the mechanism of action of synthetic steroids 
was done by Smith and Shay (1965). Working with nitrogen-substituted 
cholestanes, they observed that these compounds were inhibitory and 
lethal to cells of Sarcina lutea, From their work with S, lutea 
protoplasts, they suggested that direct action on cell membranes may 
be chiefly responsible for the antimicrobial properties of the 
steroids. The work of Varricchio (1966) lends further evidence that 
azasteroid action may be at the membrqne level. The same compounds 
used by Smith and Shay (1965) were found to be potent inhibitors of 
reduced nicotinamide adenine dinucleotide (NADH 2) oxidation with 
membrane fragments from Bacillus subtilis. The relative effectiveness 
of the azasteroids in inhibiting NADH2 oxidation paralleled their 
effectiveness in inhibiting the growth of cultures of~. subtilis or 
S. lutea, Varricchio (1969) suggested that since the azasteroids 
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are potent inhibitors of NADH 2 oxidation, the effect of the azasteroids 
on membranes may be closely linked with inhibition of electron trans-
port, Commager and Judis (1965) noted that the bacteriocidal action 
of phenols may be due to damage of permeability mechanisms, the repair 
of which is prevented by concomitant inhibition of energy-yielding 
metabolic reactions, 
Bangham, Standish and Weissmann (1965) offered evidence for an 
interaction between steroid molecules and the lipids which compose the 
limiting membranes of biological material. They suggested that 
steroids may exert their pharmacological actions and physiological 
functions, at least in part, by regulating the permeability of cells 
and their organelles and that the membrane action of biologically 
active compounds may result from their direct interaction with lipid, 
which is independent of polysaccharide, proteins or active cell 
metabolism, 
Research conducted using the steroidal diamine, irehdiamine A 
(IDA), indicated that it is a potent inhibitor of bacteriophage growth 
and macromolecular synthesis in Escherichia coli (Silver and Levine, 
1968a). Their findings that IDA affected both the influx and efflux 
of 42K at low steroid concentrations led them to conclude that the 
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primary action of steroidal diamines is on the cell membrane, resulting 
in a generalized increase in cell permeability and an inactivation of 
cellular permeases. Reversal of IDA inhibition could be achieved by 
addition of 1 mM MgC1 2. The extent of the reversal depended upon the 
length of time between the addition of IDA and the addition of magne-
sium to the growth medium (Silver and Levine, 1968b). 
The relationship between growth inhibition and the concentration 
of cells and steroid had been observed by many workers. Binding of 
steroids by protein was reported by Eik-Nes et al, (1954). This 
relationship prompted Varricchio, Doorenbos and Stevens (1967) to 
determine whether there was a relationship between antibacterial 
activity of the azasteroids and their ability to bind to the bacterial 
cell. Hartman and Holmlund (1962) had observed in earlier work that 
several microorganisms, especially fungi, were able to renders-
sitosterol non-extractable by conventional methods; moreover, B. cereus 
was found to bind 6 percent of the sterol. Varricchio et al. (1967) 
found that the azasteroid compounds were readily bound to B. subtilis 
cells in amounts exceeding the growth inhibitory amount. Further 
studies using 14c labeled cholestanone as a model compound indicated 
that approximately 50 percent of the label was bound to the membrane. 
They concluded that binding was probably nonspecific, and possibly on 
the surface of a lipid or phospholipid. 
Other workers have observed action at the cell membrane level, but 
reported that deoxyribonucleic acid (DNA) is the primary target of 
steroidal diamine action. Mahler and Dutton (1964) were the first to 
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report that the alkaloid cyclobuxine, a steroidal diamine, exerted a 
profound effect on the stability of helical polynucleotides. Mahler 
et al. (1966) concluded that strong interaction between the azasteroid 
and DNA required the presence of two amino groups on the steroid 
nucleus--a single amino group in either ring A or D being completely 
ineffective. They postulated a stable but somewhat distorted helix 
with the bases tilted, or at least no longer aligned in the same 
manner as they were in the native Watson-Crick-Wilkins B conformation--
a model in which the steroid molecules are bound but probably not 
intercalated into the DNA helix 1 
An agent capable of strong interaction with DNA might be expected 
to affect mutation rates in vivo. In work with IDA and malouetine, 
Mahler and Baylor (1967) demonstrated that steroidal diamines are 
mutagens and effective inhibitors of phage replication and postulated 
that DNA was the primary target of diamine action in vivo. IDA was 
found to effectively inhibit the reproduction cf bacteriophages T2 
and T4. Addition of IDA, either at zero minutes or after ten minutes, 
virtually stopped DNA synthesis, with effects on messenger RNA and 
protein synthesis being less pronounced. They co~cluded that trans-
cription and translation are relatively insensitive to steroid action--
the most sensitive event being the formation of the first few copies 
of parental DNA. 
Binding to DNA was also found bY Krey and Hahn (1969) in their 
work with the alkaloid, berberine. Berberine shifted the thermal 
strand separation profile of DNA to higher temperatures, thereby 
suggesting the formation of a complex between the alkaloid and DNA. 
Further evidence for binding to DNA was suggested by the addition of 
increasing concentrations of DNA to berberine which progressively 
decreased the absorption intensity of ~he two bands of the berber;ne 
spectrum, 
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As the search for new and better antibiotics continues many work-
ers have focused their efforts on enhancing the effect of known 
antibiotics. Recent work by Riehm and Biedler (1972} described the 
potentiation of the drug effect obtained when Tween 80, a nonionic 
detergent, is used in combination with actinomycin D or daunomycin, 
Chinese hamster cells resistant to actinomycin D and daunomycin were 
found to be much more sensitive to drug action when the antibiotics 
were used in combination with Tween 80. The synergistic effect was 
found to occur even at demonstrably nontoxic concentrations of Tween 80 
for sensitive and resistant cells. 
E. coli cells are normally impermeable to actinomycin D, which 
-r --.. . 
inhibits DNA-dependent RNA synthesis and the consequent inducib1e 
enzyme synthesis. Leive (1965) has shown that E, coli cells treated 
-~
with EDTA are more susceptible to actinomycin D and that lipopoly-
saccharide is released from the cell wall. Roy and Mitra (1970) also 
reported lipopolysaccharide release with a sma11 filamentous phage, 
M 13. I· coli K-12 cells infected with M 13 were shown to be permeable 
to actinomycin D and release lipopolysaccharide into the medium. 
Since action at the membrane level would allow quicker entry of 
molecules into the cell, membrane active antibiotics should pQtentiate 
the action of other antibiotics with internal sites of action, Both 
polymyxin and circulin are surface active antibiotics thought to cause 
disorganization of the cell membrane leading to a loss of intracellular 
components (Coleman, 1969}. Potentiation studies utilizing polymyxin, 
circulin and actinomycin D were conducted during the course of this 
present investigation to determine the biological effect produced when 
these antibiotics were used in combination with a new azasteroid 
compound. 
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This thesis is concerned with the mode of biological action of a 
new hydroxypyrazole compound (Fig. 1) synthesized by Dr. K. D. Berlin 
and Dr. J. G. Morgan at Oklahoma State University (Morgan et al., 1971). 
The molecular weight of the compound is 236 with a melting point of 
257-260 C. The structure of the compound suggests a potential for 
surfactant properties--the benzene rings would constitute the large 
non-polar nucleus with the hydroxyl group and two nitrogen groups 
contributing polar properties to the molecule. 
The aromatic nucleus of the molecule gives the compound two 
properties which make it conducive to biological assay under test 
conditions. The first property is the ultraviolet (UV) absorption 
spectrum of the compound. Absorption scanning in the UV range indi-
cates peaks of 258, 266, 300 and 312 nm (Fig, 2). The peak at 312 nm 
permits quantitation of the compound in growth medium under conditions 
in which 260 nm absorbing material may be released from the bacterial 
cell. The second property of the aromatic nucleus which can be used 
in assay procedures is its f'luorescent characteristics. The hydroxy-
pyrazole compound has fluorescent excitation peaks at 250, 268, 302 
and 320 nm. The emission spectrum shows a single emission peak at 
382 nm (Fig. 3). 
It is the purpose of this paper to suggest the possible mode(s) 
of action of the hydroxypyrazole compound as well as illustrate 
potential use of the compound as a therapeutic agent in combination 
Figure 11 The Hydroxypyrazole Compound. T~e molecule has a large 
non~polar nucleus with a polar hydroxy group attached 
to t~e number 3 ~arbon.and polar nitrogens incorporated 








Figure 2. UV Spectrum of the HydroxypyNz:ole Compound, The Gompound 

















Figure 3. Fluorescent excitation and Emission Spectra of the Hydroxy-
pyrazole. The compound exhibits excitation maxima at 
250, 268, 302 and 320 nm with a single emis~ion peak at 
3a2 nm. (~. ~ .. ), excitation spectr~m with emission wave~ 
length of 382 nm; (p-~), emission spectrum with excita~ 
tion wavelength of 3?0 nm. 
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with various antibiotics. The compound has surfactant properties which 
are manifested by its action on sheep red blood cells and B. subtilis 
W23 protqplasts. Thermal melting curves of isolated P. fluorescens - . .. . ' 
DNA and mutagenic studies utilizing ~· subtilis 168, an indoleless 
strain, offer evidence that the compound may also have an action at the 
DNA level. Antibiotic potentiation studies using Pseudomonas organisms, 
a genus notorious for its resistance to antibiotics, indicate a 
potential use as a chemotherapeutic agent against Pseudomonas infec-
tions. The hydroxypyrazole greatly enhances the action of actinomycin 
D against E· f1uorescens1 Experiments using the UV and fluorescent 
characteristiqs of the compound indicate that it complexes with the 
actinomycin D mole~ule. The compound possesses no estrqgenic proper-
tie~ and produces no toxic effect in treated animals which further 
emphasizes its potential as a therapeutic agent, 
CHAPTER II 
MATERIALS AND METHODS 
Te$t Orga,nisms 
The microorganisms used in this study were obtained from the 
stock culture collection of Dr, N. N. Durham, Oklahoma State 
University. Orie of the organisrns, Pseudomonas fluorescens, has been 
tentatively identified by Montogomery (1966). It is a, gram~negative, 
motile rod which forms smooth, raised colonies on nutrient agar. The 
organism exhibits a ne~ative reaction fqr hydrogen sulfide production, 
indole production and nitra,te reduction, and produces acid but no gas 
in glucose. This organism also produces fluorescein and pyoGyanin 
when grown on Bacto~Pseudomonas agar F and Bacto-Pseudomona,s agar P, 
respectively. Bacillus subtjlis W23 is a prototrophic strain 
initially obtained from Dr, W. C. McDonald, Tulane University. It is 
a gram-positive, motile organism with an optimal growth temperature of 
37 C. §_. subtilis 168, which has a growth requirement for indole or 
L-tryptophan (Anagnostopoulos and Spizizen, 1961), was used in the 
mutagenic phases of this study. 
Stock cultures off. fluorescens, _!!. subtilis W2~ and_!!. subtilis 
168 were maintained on slants of succinate-salts, glucose-salts and 
nutrient agar, respectively, and stored at 4 C. 
Synthetic Media 
The 0,2 percent succinate-salts synthetic medium used in this 
study had the following composition: 0.2 percent NaCl, 0.2 percent 
NH4c1, Q.32 percent KH 2Po4 and 0.42 percent K2HP04. Succinate was 
autoclaved separately and added aseptically to the sterile minimal 
salts base. The pH of the succinate was adjusted to 7.0 with KOH 
prior to sterilization. Sterilization was achieved by autoclaving 
for 15 minutes at 121 C, After cooling to room temperature, the 
medium was supplemented with 0.1 ml of a sterile mineral salts 
solution for each 100 ml of the medium. The mineral salts solution 
had the following composition: 5.0 percent MgS04 · 7H 20, 0.1 percent 
Mnso4, 1.0 percent FeC1 3 and 0.5 percent CaC1 2, Two percent agar 
(Difeo) was added when a solid medium was required. 
The basal medium for the 0.5 percent glucose-salts had the 
following composition: 1.4 percent K2HP04, Q.6 percent KH2Po4 and 
0.2 percent (NH4)2so4, Glucose was autoclaved separately and added 
aseptically to the sterile minimal salts base. After cooling to room 
temperature following sterilization, the medium was supplemented with 




Actinomycin D (Merck, Sharp and Dahme Research Laboratory), 
polymyxi n (Pfizer Chemical Company), lysozyme (Worthington ~iochemi ca 1 
Corporation), calf thymus DNA and guanosine 51 -monophosphoric acid 
(Sigma Chemical Company) were dissolved in sterile glass-distilled 
water, and stock solutions stored at 4 C. The concentrations of all 
chemicals used in this study are recorded in the text. 
Spectrophotometric St~dies 
The UV absorption spectra of aqueous solutions of the hydroxy-
pyrazo1e, actinomycin D, calf thymus DNA, and guanosine 51 -monophos-
phoric acid (GMP) were determined using a Cary 14 recording spectro-
photometer. Appropriate controls were used when the spectrum of a 
mixed solution (hyqroxypyrazole plus actinomycin D, DNA or GMP) was 
determined, The spectrum of each compound or mixture of compounds 
was determined between the wavelengths of 220-340 nm using quarti 
cuvettes with a l cm light path. 
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The fluorescent excitation and emission spectra of the 
hydroxypyrazole compound in water was determined on an Aminco-Bowman 
scanning spectrophotofluorometer using quartz cuvettes with a 1 cm 
light path. The emission and excitation spectra were determined 
between the wavelengths of 200-500 nm. After the peak excitation and 
emission wavelengths were determined, further fluorescent determina-
tions were made using a Hitachi photofluorometer. The hydroxypyrazole 
was excited at 320 nm, and the emission measured at 382 nm, 
Growth Inhibition 
Studies were conducted to determine the effect of the hydroxy-
pyrazole on growth off. fluorescens and].. subtilis. W23 cells, The 
organisms were grown 10-12 hours in sterile tubes (18 x 150 mm) 
containing 6.0 ml of the appropriate medium. Aeration was provided 
by shaking on a reciprocal shaker (100 oscillations per minute) with 
an incubation temperature of 37 C. These cells were used as inocula 
for growth studies which were performed in test tub~s (18 x 150 mm) 
containing a total volume of 6.0 ml, Growth was followed by reading 
the absorbance at 540 nm on a Coleman Junior II spectrophotometer. 
19 
Dose response assays of the hydroxypyrazole and Vij;rious anti-
biotics, used separately or in combination, were determined by addi~ion 
of the appropriate test compound(s) in increasing concentrations to the 
culture at time sero. The inhibition was measured by following the 
absorbance of the culture at 540 nmo 
Reversal of the hydroxypyrazole inhibition of growth was deter-
mined by growing .§_, subtilis W23 cells in glucose-salts minimal medium 
in the presence and absence of the compound. After the inhibition had 
been established and the control cells were well into log phase, 
the cells were centrifuged (6,000 x g) for 10 minutes under aseptic 
conditions and suspended in potassium phosphate buffer (pH 7.0; 10 mM) 
to the same absorbance. The cells were then inoculated into glucose~ 
salts medium in the presence and absence of the compound. Growth was 
'determined by fo 11 owing the absorbance at 540 nm. •• 
Manometric Studies 
The possible use of the hydroxypyrazole as a carbon source by 
P. fluorescens was determined by following oxygen uptake in a Warburg. 
apparatus at 37 C, Cells were grown in the succinate-salts medium for 
18 hours, transferred to fresh medium and grown for 6 aciditional hours. 
The cells were harvested by centrifugation (6,000 x g) for 10 minutes 
and suspended to an absorbance of 0,85 at 540 nm in minimal salts 
buffer with no carbon source. The Warburg flasks contained a total 
volume of 2o7 ml with 0.2 ml of a 20 percent solution of KOH placed 
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in the ~enter well to absorb co2 released during the course of the 
experiment. Cells (2.3 m1) were placed in the flasks with 0.2 ml of 
either water~ 0.05 M ~lucose or 20 .ug/ml hydroxypyrazole to determine 
endogenous respiration, respiration in the presence of glucose, and 
respiration in the presence of the hydroxypyrazole, respectively. The 
amount of o2 uptake (µt) was determined at 10 minute intervals. 
-Cell Wall Isolation 
B. subt11is W2~ cell walls were isolated by the procedure ef Best 
and Durham (1965) except the isolated cell walls were further purified 
by twice heating to boiling in a water bath while suspended in 1.0 
percent sodium laural sulfate in pH 9.0 Tris buffer (0.05 M Tris 
plus 0.005 M magnesium sulfate). The trypsinization and washing steps 
were then performed according to the procedure of Best and Durham 
(1965), The cell walls were 1yophilized and stored at 4 C. 
Sinding Studies 
Binding of the hydroxypyrazole compound to B. subtilis W23 cell 
walls was determined by exposing a fixed amount of cell walls to 
increasing concentrations of the compound. Lyophilized cell walls 
were prepared as described above and suspended to a concentration of 
0.1 mg/ml in sterile glass-distilled water. Aliquots (l.O ml) of this 
suspension were pipetted into 8 tubes and pelleted by centrifugation 
(27,000 x g for 15 minutes). The pellets were suspended in increasing 
concentrations of hydroxypyrazole (l .0-8.0 pg/ml final concentration) 
in a total volume of 5.0 ml. The samples were allowed to sit for 10 
minutes at room temperature, centrifuged (27,000 x g for 15 minutes), 
and the absorbance of the supernatant solution read at 312 nm. The 
amount of hydroxypyrazole adsorbed per sample was then calculated by 
comparing against a standard curve of the hydroxypyrazo1e measured at 
312 nm (Fig. 4). 
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Adsorption to B. subtilis W23 whole cells was determined in a 
similar manner. Cells were grown 10-12 hours on glucose-salts medium, 
harvested by centrifugation (6,000 x g for 10 minutes), washed with 
Potassium pho$phate buffer (pH 7.0; 10 mM) and suspended to a concen-
tration of 0.3 mg/ml. Aliquots {l.O ml) of this suspension were 
pipetted into 6 tubes and pelleted by centrifugation (10,000 x g for 
10 minutes). The pellets were suspended in increasing concentrations 
of the hydroxypyrazole (3.0-15.0 µg/ml final concentration) and 
allowed to sit for 10 minutes at room temperature. ~he cells were 
pelleted by centrifugation (10,000 x g for 10 minutes) and the absorb-
ance of the supernatant solution determined at 312 nm. The number of 
binding sites per cell was determined by finding the number of cells 
present in the 0.3 mg pellet by viabl~ cell count, then comparing the 
amount of hydroxypyrazole necessary for saturation. The cells were 
agitated vigorously with a Vortex mixer to help eliminate chained 
cells. 
Protoplast Preparation 
Protoplasts of_!!. subtilis W23 were prepared by growing the cells 
10-12 hours on glucose-salts agar plates. The cells were harvested 
using potassium phosphate buffer (pH 7.0; 10 mM), pelleted, and washed 
twice by centrifugation (6,000 x g for 10 minutes) in buffer, The 
pellet was suspended in 30 ml of 0.6 M suqrose containing lysozyme 
Figure 4. Standard Curve of the Hydroxypyrazol e at 312 nm, Hydroxy~ 
pyrazole absorption at 312 nm was measured by dissolving 
various concentrations of the compound in distilled 
water and reading the absorbance on a BeGkman DU spectra~ 
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(400 ~g/ml) and allowed to sit at room temperature under nitrogen gas 
for 2 hours. Protoplast formation was confirmed by phase-contrast 
microscopy. The protoplasts were further purified by a slow speed 
centrifugation (2,000 x g for 5 minutes) to eliminate whole cell or 
cell ghosts from the preparation. 
Effect of Hydroxypyrazole on Membranes 
The effect of the hydroxypyrazole compound on membranes of 
procaryotic and eucaryotic cells was determined using~· subtilis W23 
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protoplasts and sheep red blood cells. Protoplasts of B. subtilis W23 - . . 
were prepared as described above, The amount of protoplasts 
necessary to give a final absorbance of 0.2 at 540 nm for a 5,0 ml 
sample was determined. The pr~toplasts were then pipetted into two 
tubes. Five ml of 0.6 M sucrose was added to one tube as a control, 
and 5.0 ml of the hydroxypyrazole (20 pg/ml) made up in 0.6 M sucrose 
was added to the second tube. The absorbance at 540 nm was followed 
to determine lysis or membrane leakage. 
Three day old sheep red blood cells were used for determining the 
effect of the hydroxypyrazole on eucaryotic membranes. The red blood 
cells were washed 3 times in physiological saline solution (PSS) 
by centrifugation (6,000 x g for 5 minutes). The amount of cells 
necessary to give a final absorbance of 1.0 at 412 nm when lysed in 
5.0 ml of water was determined, Aliquots were then pipetted into 3 
tubes. Five ml of water, PSS or hydroxypyrazole (20 pg/ml) dissolved 
in PSS wa$ added to the tubes to determine 100 percent lysis, leakage 
in PSS and the effect of the hydroxypyrazole on the cell membrane, 
respectively. The tubes were allowed to sit at room temperature for 
25 
24 hours. The intact cells were pell~ted by cent~ifugation (10,000 x 
g for 10 minutes), and the absorbance of the supernatant solution read 
at 412 nm to determine leakage of hemoglobin from the cell. 
Uptake of Radioactive Substrates 
Glucose-salts grown§_. subtilis W23 cells were used to assay the 
effect of the hydroxypyrazole on uptake of 14c labeled substrates. 
Cells were grown 10-12 hours, and then inoculated into two 250 ml 
side arm flasks containing 15 ml of fresh medium to an absorbance 
of 0.1 at 540 nm. The cells were in cu bated at 37 C in a shaking 
water bath (100 oscillations per minute) until growth was initiated. 
Initiation of the uptake experiment was marked by the addition of the 
following compounds to the growing cultures: 0.2 ml of 14c labeled 
substrate (5~C/ml}, 0,5 ml of cold carrier substrate (1 mg/ml) and 
either 2.0 ml of hydroxypyrazole (87 pg/ml) or water as a control. 
$amples (l.O ml) were taken at the indiqated time intervals and 
filtered through a Millipore filter (10 mm diameter, 0.45 micron pore 
size). The filters were washed 3 times with 1.0 ml volumes of 
potassium phosphate buffer (pH 7,0; 10 mM) and allowed to air dry. 
The filters were then placed in counting vials and 10 ml of Aquasol 
(New England Nuclear) added. Radioactivity was determined using a 
liquid scintillation counter (Nuclear Chicago) with a counting effi-
ciency of 40 percent for 14c under these condition, 
Incorporation of Radioactive Substrates by Cells 
The procedure for determining incorporation of 14c labeled 
substrates was the same as for measuring uptake except that the cells 
were washed 3 times with 1~0 ml volumes of cold 5 perqent trichloro-
acetic acid (TCA) instead of using potassium phosphate buffer. 
Duration of the sampling time was 1 hour with samples taken at the 
indicated times, 
Mutagenic Studies 
B. subtilis 168, an indoleless strain, was used to determine if - ' 
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the hydroxypyrazole affected the mutation rate of bacteria, Cells, 
grown 10-12 hours in nutrient broth, were used as the inoculum for 
fresh nutrient broth with or without th~ hydroxypyrazole compound. 
Cells {0.1 ml) were inoculated into tubes {6.0 ml total liquid volume) 
containing nutrient broth plus hydroxypyrazqle {12 pg/ml) or water 
as the control. The cells were incubated at 37 Con a reciprocal 
shaker {100 oscillation per minute), and the absorbance at 540 nm 
was followed. The cells were plated on nutrient agar and glucose~ 
salts agar using the pour plate method when the cells attained an 
absorbance of 0.50 to determine the total number of cells present and 
the number of rev~rtants to indole positive, respectively. A viable 
cell count of the initial inoculum {O,l ml) was also performed using 
nutrient agar to determine the number of cells present initially. The 
plates were incubated 24-48 hours at 37 C to allow colony formation, 
then scored for colony forming units to determine the effect of the 
hydroxypyrazole on mutation rate. 
DNA Isolation 
P. fluorescens DNA was isolated using a modification of the 
procedure of Marmur {1961), P. f1uorescens cells were grown 10~12 
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hours in a 2 liter Fernback flask containing 500 ml of succinate-salts 
broth, These cel1s were used to inoculate 7 liters of succinate~salts 
medium. Growth was accomplished by incubation a~ 37 C on a Microferm 
Model MF-214 Table Top Fermentor (New Brunswick Scientific Company). 
The culture was stirred at 400 rpm and aerated with sterile forced air 
(5 psig). 
After the cells reached maximum stationary phase, they were 
harvested by centrifugation (6,000 x g for 10 minutes) and suspended 
in 10 ml of NaCl-EDTA (0,10 M NaCl-0,15 M EDTA, pH 8,0), Lysozyme 
(10 mg/ml) was added to give a final concentration of 100 µg/ml, and 
the suspension placed on a reciprocal shaker at 37 C for 1 hour. 
Duponal (30 percent) was added to a final concentration of 3 percent, 
After complete ly?is was observed microscopically, 5 M sodium per-
chlorate was added to a final concentration of 1,0 Mand the suspension 
permitted to stand at room temperature for 1 hour. 
Deproteinization was accomplished by repeated shaking with an 
equal volume of chloroform-isoamyl alcohol (20:1) for 30 minutes. The 
aqueous and chloroform phases were separated by centrifugation at 
3500 x g for 10 minutes. After pipetting off the top aqueous phase 
containing the nucleic acid, 2 volumes of cold 95 percent ethanol was 
gently layered on the aqueous phase to precipitate the nucleic acid 
strands, When these layers were gent1y mixed with a stirring rod, the 
nucleic acid strands could be spooled on the rod as a threadlike 
precipitate and removed. These strands were dissolved in 0.015 M 
sodium chloride-0.0015 M sodium citrate. Sufficient 1.5 M sodium 
chloride-0.15 M sodium citrate was added to give a final concentration 
of 0.15 M sodium chloride-0,015 M sodium citrate, 
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The deproteinization procedure was repeated until the protein 
interface was almost completely removed. Ribonuclease (1 mg/ml), 
previously heated to 100 C for 10 minutes, was added to the dissolved 
nucleic acid to give a final concentration of 50 pg/ml, The suspension 
was placed at 37 C for 1 hour. Deproteinizatton and alcohol precipi-
tation was repeated until no protein appeared at the interface. The 
DNA strands were stored in cold 95 percent ethanol. 
DNA Melting Studies 
Melting studies on E· fluorescens DNA, isolated as described above, 
wer~ performed using the procedure of Kerr (1963). The effect of the 
hydroxypyrazole compound (2.0 µg/ml) and actinomycin D (20.0 µg/ml), 
used separately and in combination, on DNA melting was determined. 
Effect of the Hydroxypyrazole 
on Tissue Culture Cells 
The effect of the hydroxypyrazole compound on growth of tissue 
culture cells was determined using KB and LM cell strains. These 
experiments were graciously performed by Dr. Louise Higgins. The 
experimental procedure is as described by Higgins et al. (1972). 
CHAPTER III 
RESULTS AND DISCUSSION 
Effect of the Hydroxypyrazole on 
Growth of B. subtilis W23 
Since many azasteroid compounds are known to possess antimicrobial 
activity, experiments were conducted to detennine the effect of the 
hydroxypyrazole on microbial growth, The compound proved to be a 
potent growth inhibitor of!· subtilis W23 (Fig. 5). A concentration 
of 2 µg/ml completely inhibited growth for 6 hours, and 1 µg/ml 
produced a 2 hour lag in the initiation of growth and a 60 percent 
inhibition after 6 hours. Further e~perimentation, using different 
initial cell masses, indicated that the inhibition was dependent on 
both cell mass and the concentration of the hydroxypyrazole (Table I). 
Growth inhibition experiments indicated that f.· fluorescens cells 
were not sensitive to much higher concentrations (20 µg/ml) of the 
hydroxypyrazole. These results are consistent with the report of 
Smith, Shay and Doorenbos (1963a) that sensitivity to steroids was 
essentially limited to the gram-positive microorganisms. 
It should be noted that!· subtilis W23 cells inhibited by 2 µg/ml 
of the hydroxypyrazole will initiate growth upon prolonged incubation 
(10-12 hours). This would indicate that resistant organisms are 
present and/or the compound is bacteriostatic rather than bacteriocidal. 
The cells might also undergo some physiological adaptation to the 
?Q 
Figure 5. Effect of the Hydroxypyrazole on Early Log Growth of 
B. subtilis W23. ~.control; .._, l µg/ml hydroxy~ 
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*Concentration of the hydroxypyrazole was 5.0 pg/ml. 
**Incub~tion temperature was 37 C on a reciprocal shaker (100 
oscillation~ per minute). 
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hydroxypyrazole. UV spectral analysis indicates that the compound i$ 
not broken down by shaking at 37 C. 
Reversal of Hydroxypyrazole Inhibition 
Since the hydroxypyrazole inhibited B, subtilis W23 cells, studies 
were initiated to determine if the effect was bacteriostatic or 
bacteriocidal. Experiments were conducted to determine if inhibited 
cells would initiate growth when placed in fresh growth medium contain-
ing no hydroxypyrazole. The results indicated that growth inhibition 
was reversed after 2 hours incubation in fresh medium with the growth 
rate of the reversed cells being approximately the same as the control 
(Fig. 6). Cells suspended in medium containing the compound were 
completely inhibited for the full 9 hours of the experiment. These 
results established that the hydroxypyrazole is bacteriostatic rather 
than bacteriocidal. 
Use of the Hydroxypyrazole as a 
Carbon Source by P. fluorescens - . ' 
Mazur and Muir (1963) reported that Nocardia sp. A. T. C. C. 
14558 was capable of dehydrogenating certain azasteroids with nitrogen 
in the C ring. Experiments were conducted to determine if f. 
fluorescens could oxidize the hydroxypyrazole as a source of carbon 
and energy. Oxygen uptake was measured in a Warburg apparatus and 
.glucose was used as a substrate control. Cells incubated in the 
presence of the hydroxypyrazole demonstrated a respiration curve that 
coincided with endogenous respiration for the time examined, indicating 
that P. fluorescens did not oxidize the hydroxypyrazole (Fig. 7). 
Figure 6. Reversal of Hydroxypyrazole Inhibition in B. subtilis W23 
Cells. Hydroxypyrazole concentration was 10 pg/ml. 
~'control; ~' hydroxypyrazole inhibited then placed 
i 9 fresh medium; • , hydroxypyrazo 1 e inhibited then 
placed back in hydroxypyrazole; ~' control cells placed 














Figure 7. Warburg Resp1 rometry of P. fl uorescens Cells. e, glucose 
(0~0037 M) control; A, enaogenous respiration; • ' 
resp1rat1on in the presence of the hydroxypyrazole 
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These results are further substantiated by growth exp~riments in 
which f· fluorescens cells were inc~bated in basal salts medium supple-
mented with the hydroxypyrazole a~ the sole carbon source, No growth 
occurred upon extended incubation under these conditions 
Binding of the Hydroxypyrazole to Isolated 
B. subtilis W23 Cell Walls ...,.... 
Varricchio et al. (1967) observed a relationship between the con-
centration of azasteroid necess1;1ry to inhibit growth and bacterial 
cell concentration and postulated that the azasteroid molecule may bind 
to the cell. Hartman and Holmlund {1962) had observed earlier that 
several microorganisms, especially fungi, were able to render certain 
steroids nonextractable by conventional means. 
Experiments were conducted to determine if the hydroxypyrazole 
exhibiteq similar binding characteri~tic$. Binding studies utilizing 
isolated cell walls of B, subtilis W23 were conducted using the UV 
"'°:r' I ' . 
absorption peak of the hydroxypyrazole at 312 nm to assay the amount 
bound. Using a constant amount of cell walls (O.l mg dry weight), 
increasing concentrations of the azasteroid were added until saturation 
was achieved at the 30 pg level (Fig. 8). 
The theoretical maximum adsorpti9n can be determined by graphing 
these data in a double-reciprocal plot and taking the reciprocal of 
the point where the line crosses the y~axis {Fig. 9). It was deter-
mined that approximately 5 x 1016 molecules of the hydroxypyrazole are 
bound per 0.1 mg of cell wall. Washing of cell walls to which 
azasteroid had been bound indicated that 20 percent of the compound 
was released by washing with water, and an additional 5 percent ~as 
Figure 8. Hydroxypyrazole Binding to B. subtilis W23 Cell Walls 
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Figure 9. Double-Reciprocal Plot of Hydroxypyrazole Binding t~ 
B. subtilis W23 Cell Walls (0.1 mg dry weight). - .. , ' 
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removed by further washing with l mM MgC1 2. Therefore, 75 percent of 
the hydroxypyrazole was tightly bound to the cell wall with the remain-
ing 25 percent being somewhat more loose1y bound. 
Binding of the Hydroxypyrazole to 
B. subtilis W23 Whole Cells 
Binding of the hydroxypyrazole to B. subtilis W23 whole cells - ' 
was studied to determine the number of binding sites present on the 
cell. Using 0.3 mg dry weight of whole cells, saturation by the 
hydroxypyrazole was achieved at the 50 µg level (Fig, 10). By graphing 
in a double-reciprocal plot, it was determined that 3 x 1016 molecules 
bind per 0.3 mg dry weight of!!_, subtilis W23 whole cells or 1 x 101 6 
molecules per 0.1 mg of whole cells (Pig. 11). Using these data and 
the number of cells present in 0,3 mg dry weight of~· subtilis W23 
whole cells, it was determined that approximately 1 x 108 binding sites 
exist per cell. 
Since the binding to isolated cell walls yielded a value of 
5 x 1016 molecules per 0.1 mg, it would appear that the isolated cell 
wall will bind 5 times the amount bound by whole cells. However, if 
the fact that the cell wall is approximtely one-fifth of the total cell 
weight is considered, the two values are compatible, 
Using cholestanone as a model steroid, Varricchio et al. (1967) 
determined that 16 percent of the steroid was bound by~· subtilis 
whole cells. Hartman and Holmlund (1962) reported a 6 percent binding 
of the sterol, s-sitosterol, to~· cereus cells. A value of 10 percent 
binding of the available hydroxypyrazole was obtained for~· subtilis 
W23 whole cells (Fig. 10). Therefore, the percent binding of the 
Figure 10. Hydroxypyrazole Binding to_!!. subtilis W23 Whole Cells 
(0.3 mg dry weight), 
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hydroxypyra~ole to_!!. subtilis W23 generally corresponds with binding 
by cholestanone and s-sitosterol. 
Effect of the Hydroxypyrazole on 
a Eucaryotic Membrane 
48 
Smith, Shay and Doorenbos (1963b) were the first to devote atten-
tion to the mechanism of action of azasteroid compounds. Working with 
nitrogen-substituted cholestanes,they observed spontaneous lysis of 
sheep and human red blood cells. Experiments utilizing 3 day old 
sheep red blood cells were conducted to ascertain if the hydroxypyra-
zole caused damage at the membrane level (Table II). The results 
indicated that the compound caused an increased leakage of the hemo-
globin from the cell. Three times as much hemoglobin was released 
from treated cells when compared to the control after 24 hours 
incubation. Although a membrane effect may be evident, it should be 
noted that the action of the hydroxypyrazole was not as severe as that 
observed with detergents and membrane active antibiotics since a 
period of 24 hours was required to release approximately 30 percent 
of the total hemoglobin as compared to a 10 percent leakage by the 
control. 
These results are in agreement with the work of Smith, Shay and 
Doorenbos (1964) who reported that 50 percent of the sheep red blood 
cells remained intact after 16 hours following treatment with a 
nitrogen-substituted cholestane. 
TABLE JI 
EFFECT OF THE HYDROXYPYRAZOLE ON HEMOGLOBIN 









*Lysis was accomplished by suspending the red blood cells in 







**The hydroxypyrazole was dissolved in PSS to a concentration of 
20 µg/ml. 
Effect of the Hydroxypyrazole on 
a Procaryotic Membrane 
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The effect of the hydroxypyrazole on~' subti1is W23 protop1asts 
was also examined. Whole cells were converted to protoplasts by 
treatment with lysozyme (400 µg/ml) in the presence of a stabilizing 
medium (0.6 M sucrose). As with the red blood cell experiment, the 
action of the compound on the membrane was slight, causing very little 
decrease in optical density for the first 6 hours (Fig. 12). A 
decrease in optical density is evident after 6 hours, which is indica-
tive of lysis, Microscopic observation indicated that clumping did 
not occur and that some of the protoplasts were morphologically intact 
after 24 hours. However, the protoplasts in the presence of the 
hydroxypyrazole did not swell like the control protoplasts. This 
could indicate leakage, res~lting in the protoplasts inability to 
maintain as high an internal pressure as the control. 
Swelling of the control protoplasts results from the protoplasts 
being in a hypotonic environment (0.6 M sucrose). Approximately 2,5 M 
sucrose is required to completely staqilize B. subtilis protoplasts; - ,,. 
however, significant lysis of protoplasts occurs only at sucrose 
concentrations below 0.5 M (Corner and Marquis, 1969). The bacterial 
cell is able to assimilate from the external medium soluble substances 
such as amino acids, purines, pyrimidines, nucleotides, phosphate and 
other ions. The cell can create a concentration gradient across the 
cell surface as high as 400 to 500 times. Consequently, a high 
osmotic pressure is set up within the cell that may be as high as 
20-25 atmospheres for gram-positive bacteria (Gale, 1963). 
Action of the hydroxypyrazole on~- subtilis W23 protoplasts is 
Figure 12. Effect of the Hydroxypyrazole on B;·subtilis W23 
Pro top 1 as ts. e, contra 1 in 0 .6 M 51,Jcrose; A , 
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consistent with the work of Smith and Shay (1965) who observed that 
nitrogen-substituted cholestanes caused lysis of protoplasts of 2_. 
lutea and also with the work of Silver and Levine (1968a) who postu-
lated that the action of IDA was at the membrane level. 
Effect of the Hydroxypyraz~le on Uptake 
of Labeled Substrates 
53 
Experiments utilizing~· subtilis W23 protoplasts and sheep red 
blood cells demonstrated that the hydroxypyrazole has an action at the 
membrane level; however, this action is slight, resulting in leakage 
of cellular constituents rather than lysis. Experiments were conducted 
to determine if the uptake of labeled substrates was affected by the 
hydroxypyrazole using~· subtilis W23 cells. 
The substrates selected for the uptake experiments were uracil, 
serine and glucose. The uptake of 14c-uracil (specific activity 
40.6 mC/mM) was reduced by approximqtely 60 percent by the presence of 
the steroid (Fig. 13); however, the uptake of 14c-serine (specific 
activity 87 rnC/mM) and 14C-glucose (specific activity 55 mC/mM) was 
not inhibited. This wou19 indicate that inhibition of uptake is not 
of a generalized nature and that uracil is specifically inhibited by 
the hydroxypyrazole. These results would support the hypothesis that 
action at the membrane is slight; moreover, it is not sufficient to 
cause a generalized leakage of labeled substrates from the cell in the 
4 minute uptake period. 
Figure 13. Effect of the Hydroxypyrazole on 14c~uracil Uptake in 
B! subtilis W23, ~'control; ~, hydroxypyrazole 
TlO µg/ml) treated, 
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Effect of the Hydroxypyrazole on Incorporation 
of· Labeled Substrates 
Since only the uptake of uraci1 was inhibited by the hydroxy-
pyrazo 1 e, experiments were con ducted to determine the effect of the 
compound on incorporation of labeled; substrates into cellular consti-
tuents. The concentration of hydroxypyrazole used was sufficient to 
cause only a slight inhibition of growth of the B, subtilis W23 cells . 
._,.... ' . ' 
Results indicated that 14c~serine (specific activity 87 mC/mM) 
incorporation into protein was not inhibited by the hydroxypyrazole, 
Both control and treated cells showed an identical incorporation curve 
during the 60 minute incorporation time. Incorporation of 14c-uracil 
(specific activity 40.6 mc/mM) into messenger RNA was inhibited by 
the hydroxypyrazole (Fig. 14); however, since the uptake of uracil 
was inhibited by the hydroxypyrazole, it may be that uptake w~s the 
determinant, Inhibition of incorporation of uracil into cellul&r 
components can not be clearly .separated from inhibition of uptake when 
both phenomena are occurring simultaneously. 
Potentiation of Membrane Active Antibiotics 
Since sheep red blood ce11 and B. subtilis W~3 protoplast exper; ... 
. - ' . 
ments demonstrated that the hydroxypyra;zole had an action at the 
membrane level, potentiation experiments were conducted to determine 
56 
if the compound would enhance the antibacterial action of selected 
antibiotics. Only membrane active antibiotics and actinomycin D showed 
any enhanced activity when used in combination with the hydroxypyrazole, 
The action of vancomycin, penicillin, chloramphenicol, 5-fluorouracil 
or mitomycin C was not potentiated by the hydroxypyrazole. 
Figure 14. Effect of the Hydroxypyrazole on 14c-uracil Incorporation 
in B, subtilis W23, e, control; A, hydrioxypyrazole 
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However, the action of both polymyxin and circulin, surface active 
antibiotics thought to cause disorganization of the cell membrane 
(Coleman, 1969), proved to be greatly enhanced when used in combination 
with the hydroxypyrazole, Sub-inhibitory concentrations of the 
azasteroid compound (13 pg/ml) which produced no growth inhibition in 
f. fluorescens almost completely inhibited growth when combined with 
1 )Jg/ml polymyxin (Fig. 15). Similar results were also observed when 
circulin (2,5 µg/ml) was used in combination with the hydroxypyrazole. 
Potentiation of polymyxin and circulin by the azasteroid was also 
observed using the gram-positive bacterium, ~· subtilis W23, Polymyxin 
and the hydroxypyrazole used in combination showed a marked enhancement 
of inhibition as compared to either compound used alone (Fig. 16), 
Growth was inhibited for the entire 12 hours of the experiment. 
Potentiation of Actinomycin D 
A most interesting and potentially useful discovery was made when 
the action of actinomycin D was shown to be potentiated by the hydroxy-
pyrazole, Two other anticancer drugs, 5-fluorouracil and mitomycin C, 
showed no enhanced activity when used in combination with the compound~ 
Several authors have shown potentiation of actinomycin D by agents such 
as detergents, EDTA and phage, all of which have an action on the cell 
permeability barrier similar to the proposed action of the hydroxy-
pyrazole. Riehm and Biedler (1972) recently reported that Tween 80, 
a nonionic detergent, will potentiate the drug effect of actinomycin D 
or daunomycin against resistant Chinese hamster cells. Leive (1965) 
noted that I· coli cells treated with EDTA are more susceptible to 
actinomycin D, and Roy and Mitra (1970) reported that E. coli K-12 
Figure 15. Hydroxypyrazole Potentiation of Polymyxin Action Against 
P. fl uorescens. e, control; ..& , hydroxypyrazol e 
Tl 3 µg/ml) 'treated; • , polymyxi n ( 1 µg/ml) treatep; 
4t, hydroxypyrazole (13 pg/ml) plus polymyxin 
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Figure 16, Hydroxypyrazole Potentiation of Polymyxin Action Against 
B. subtilis W23. e, control; .& , hydroxypyrazo1e 
T2.6 µg/ml treated); •, polymyxin (5 µg/ml) treated; 
tt, hydroxypyrazole (2.6 µg/ml) plus polymyxin 









cells infect~d with the small filam~ntous phage, M 13, are more 
permeable to actinomycin D. 
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Results of the potentiation experiment using the hydroxypyrazole 
and actinomycin D in combination against f. fluorescens cells indicated 
that potentiation was occurring and was quite pronounced (Fig. 17) 1 
Subinhibitory concentrations of both the hydroxypyrazole and actinomy-
cin D completely inhibited growth for 9 hours when used in combination. 
Prolonged incubation of these cells indicated that growth will initiate 
after 24 hours of incubation. 
These results suggest that the hydroxypyrazole may possibly poten-
tiate the action of actinomycin D against cancer cells. Potentiation 
experiments involving these compounds against tissue culture cells 
have proven to be inconclusive; however, results obtained with bacter-
ial cells illustrate that the potential is present. 
Molecular Complex Formation Between the 
Hydroxypyrazole and Actinornycin D 
Actinomycin D binds strongly to double-stranded DNA and inhibits 
the DNA-dependent RNA sythesis (Arison and Hoogsteen, 1970). Of all 
the antibiotics tested, actinomycin D was the only antibiotic with a 
site of action other than the membrane which demonstrated potentiation 
with the hydroxypyrazole. 
UV absorption spectra of the hydroxypyrazole compound and 
actinomycin D indicated that the two compounds may form a complex 
(Fig. la). Actinomycin D has one peak in the UV range at 240 nm; 
however, when the two compounds are mixed, an additional peak appears 
at 270 nm. Additional evidence that the two compounds form a complex 
Figure 17, Hydroxypyrazole Potentiation of Actinomycin D Action 
Against P. fluorescens. e, control; A, hydroxy-
pyrazole-(6. 7 µg/ml) treated; •, actinomycin D 
(8 µg/ml) treated; e, hydroxypyrazole (6. 7 µg/ml) 
plus actinomycin D (8 µg/ml) treated. 
.50 . 
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Figure 18, UV Absorption Spectra of Actinomycin D and the Hydrqxy-
pyrazole Actinomycin D Complex. (-....-), hydroxypyrazole 
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was f~rnished by work with two hydro~en bond breaking agent$~ dimethyl· 
sulfoxide (DMSO) and dimethylformamide (DMF). Addition of 2 M DMSO 
or DMF to the Gomplex shifted the UV curve back to normal ano prevented 
the appearance of the 270 nm absorbing peak if added prior to complex 
fprmati on. 
UV fluorescence experiments also substantiated the presence of a 
complex. The hydroxypyrazole has a fluorescent excitation maximum of 
320 nm and an emission maximum of 382 nm (Fig. 3). Addition of 
actinomycin D to the hydraxypyrazole (l:l molar ratio) quenched the 
emission peak at 382 nm by 3o-40 percent. Addition of 2 M DMSO prior 
to complex formation yielded only a 5 percent quenching effect. 
Calorimetry experiments graciously performed by Wesley White, Oklahoma 
State University, indicated that the complex had a slightly exothermic 
heat of reaction of approximately 5 Kcal/mole. These results confirm 
other evidence of complex formation between the hydroxypyrazo1e a,nd 
actinomycin D. These findings are in agreement with those of Durham 
and Keudell (1969) who postulated a complex between actinomycin D and 
protocatechuic acid which prevented interaction of actinomycin D with 
cellular DNA. 
B·inding of the Hydroxypyrazole to DNA 
Mahler and Baylor (1967) reported mutagenic properties of IDA and 
postulated that the DNA wa$ the primary site of action, Experiments 
utilizing~. subt1lis 168, an indoleless strain, indicated that the 
hydroxypyrazole compound may also function as a mutagen. Reversion to 
indole positive was approximately 8 times higher in cell~ grown in the 
presen~e of the hydroxypyrazole. 
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Since evidence indicated that the hydroxypyrazo1e may ql$o ac:t at 
the ONA 1evel, thermal melting experiments utilizing isolated E_. 
fluorescens DNA were run to determine if the hydroxypyrazole would bind ,, ( ' 
to DNA. The thermal melting curves of DNA supplemented with actinomy-
cin D alone and in combination with the hydroxypyrazole were also run 
to determine the binding characteristics of the complex. Melting was 
determined by reading the increase in absorb~nce at 260 nm as compared 
to DNA. Results indicated that the hydroxypyrazole would bind to DNA 
· as evidenced by the shift of the melting curve to higher temperatures 
(Fig. 19). The hydrox,ypyrazole anc;I actinomycin D used singly 
demonstrated the same melting curve, while the complex shifted the 
melting curve to a slightly higher temperature. Similar results were 
also obtained using commercially prepared calf thymus DNA. These 
results are in agreement with the work of Mahler and Dutton (1964) and 
Mahler et al. (1966) who observed that the three azasteroids, 
cyclobuxine, IDA and malouetine, bound to DNA and shifted the melting 
curves to higher temperatures. 
Further indication of binding of the hydroxypyrazole to DNA was 
furnished QY observing the effect of adding ONA to a solution of the 
compound. The UV absorption peaks of the hydroxypyrazole at 312 and 
~00 nm were decreased by addition of calf thY111US ONA to an aqueo~s 
solution of the compound {Fig. 20). Th~ absorbanc~ at 312 nm was 
1owered by approximately 30 percent and the peak at 300 nm virtually 
di~appeared. These results are in agreement with the observations of 
Krey and Hahn ( 1969} in their work with the al ka 1 oi d, berberi rie, They 
found that increasing concentrations of DNA progressively decreased 
the absorption intensity of the two bands of the berberine spectrum 
Figure 19. Effect of the Hydroxypyrazole and Actinomyc1n D on Thermal 
Mel ting of P. fluorescens DNA, e, contro1; A, 
hydroxypyrazole {Z µg/ml) trea~ed; •, actinomycin D 
(20 µg/ml) treated; e, hydroxypyrazole (2 µg/ml) plus 
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Figure 20. Effect of Calf Thymus DNA on the UV Absorption Spectrum of 
the Hydroxypyra zo 1 e Ccnnpound. ( ~) • hydroxypyra;zo 1 e 
absorption peaks at 300 ~nd 312 nm; ( .. --), hydroxypyra ... 
zole absorption peaks at 300 and 312 nm after addition 
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and concluded that the berberine was binding to the DNA. 
Possible 8inding to Guanosine 
5 1 ~Manophosphoric Acid 
75 
Since the hydroxypyrazole compound binds to DNA as evidenced PY 
the shift of thermal melting to higher temperatures, experiments were 
conducted to determine the site of binding on the DNA stran~:I. GolbE)rg, 
Rabinovitz and Reich (1962) found that guanine was required for binding 
of actinornycin to DNA, UV absorption spectra of uracil, thymine, 
thymidine, cytosine, adenine and gua,nosine 5' ... monophosphoric acid 
(GMP) were run in the presence and absence of the hyi;lrqxypyrrazole to 
determine if the compound caused a shift in the UV absorption spectra. 
GMP was the only nucleic acid base which demonstrated any shift in 
the UV absorption spectrum in the presence of the hydroxypyrazole 
(Fig. 21). Aside from the normal UV peak of GMP at is3 nm, a slight 
peak at 270 nm app~ared when the hydroxypyrazole was combined with GMP. 
It should be noted, however, that this peak was only evident in the 
acidic pH range. Only a slight shoulder at 270 nm was ob~erved at 
neutral pH. 
Adqition of GMP to the hydroxypyrazole (1:1 molar ratio) caused a 
' . 
slight quenching (6 percent) of the hydroxypyrazole emission peak at 
382 nm. Although this is a small quenching effeGt, none of the other 
nucleiG acid pases were observed to cause any quenching. The UV and 
fluorescent spectral changes caused by the addition of the hydroxypyra-
zole to GMP offer evidence for possible binding of the compound to 
guanine molecules in the DNA strqnd. 
Figure 21. UV Ab$orptian Spectrum of GMP and GMP Plus the Hydroxy-
pyrazole Compound, ( .. -,.,), GMP spe~trum; (..........,.), GMP 
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~ff ect of the Hydroxypyra:zo 1 e on 
Tissue Culture Cel1s 
78 
Since the hydroxypyrazole compound exhibited some potential for 
possible therape~tic v~lue, tissue culture experiments were performed 
on KB and LM cell strains to determine its effeet on viability of 
tissue culture cells, These experiments were graciously performed by 
Dr, Louise Higgins and Robert Chesnut, Oklahoma State Univel1'sity. The 
results indicated that the plating efficiency of the KB cell strain 
was not decreased significantly ~Y the hydroxypyrazole at the con~~n~ 
trations used in this study (Table III). Plating efficiency of the 
KB cells was decreased by 15 percent by a concent-ration of 1 O pg/ml of 
the hydroxypyrazole, 
Viability experiments of tissue culture ce11s were als~ performed 
by exposing LM cells to increasing concentNtions of th~ hydroxypyra-
zole (Fig. 22). A concentration of 20 pg/m1 of the hydroxy~yrazole 
caused appro0imately a 60 percent reduction in the number of viable 
cells; however, this effect was not as pronounced at the 1-10 ~g/ml 
range. These results indicate that the hydroxypyrazole will affect 
tissue culture cells; however, this effect is small at the concentra-
tions used to inhibit bacterial ce1ls in this $tudy~ 
Effect of the Hydroxypyrazole on Whole Animals 
The effect of the hydroxypyra;zole compound on whole animals was 
te~ted by Dr. Claude Desjardins, Oklahoma State University, Since the 
hydroxypyraz;ole was modeled after the female hormone, eq1.1i1enin, 
experiments were conducted to determine if the compound poss~ssed 
estrogenic activity. Female mice were injected subcutaneously with 
TABLE III 
EFFECT OF THE HYOROXYPYRAZOLE COMPOUND ON PLATING 
EFFICIENCY OF KB CELL STRA~N GROWN IN STATIONARY 
CULTURES AND COUNTED AFTER SIX DAYS 
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Figure 22. Effect of the Hydro~ypyrazol~ on Viability of lM Tissue 
Culture Cells~ e, control; 4, 1 µg/ml of the 
hydroxypyrazole; •, 10 µg/ml of th~ hydroxypyrazol~; 
4t , 20 µg/ml of the hydroxypyrazole. 
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the hydrqxypyrazo]e over a 7 day period. Mea$ur~ments were made to 
ascertain the eff~ct on toti;i.l body weight, uterine weigh~ and gross 
effect on major organs. 
Results indicated that the hydroxypyrazo1e caused no effect on 
~ither total body weight or uterine weight 1 Subjective ~n$pection of 
th~ lungs, liver, spleen, intestines, kidney ~nd mammary glands for 
gross lesions did not yield any detectable or striking differenGes 
between the control and treated animals. Therefore, it appears that 
the hydroxypyrazqle possesses no estrogenic properties and causes no 
toxic effect in at least one type of whole animalp 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
The hydroxypyrazole compound proved to be a potent inhibitor of 
gram-positive bacteria, Action against gram-negative bacteria was 
diminished; however, the compound did potentiate the action of membrane 
active antibiotics and actinomycin D against both gram-positive and 
gram-negative bacteria. These results are in agreement with the work 
of Smith, Shqy and Doorenbos (l9q3a) who found that sensitivity to 
steroids was essentially limited to the gram-positive microorganisms. 
Growth inhibition by the hydroxypyrazole was found to be reversible by 
incubating the cells in fresh medium in the absence of the compound, 
Inhib,ition was dependent upon concentration of the hydroxypyrazole and 
the nature and cell mass of the microorganism. 
The hydroxypyra;;;":ole was capable of binding to both whole ce1ls and 
isolated cell walls of~· subtilis W23. Binding to the cell could 
aecount for the pronounced inhibition of gram-positive cells by a low 
concentration of the hydroxypyrazole. B. subtilis W23 possessed - ' 
approximately 1 x 108 binding sites per cell for the hydroxypyrazole, 
T~enty percent of the hydroxypyrazole could be removed from B, subtilis 
W23 cell walls by washing with water and an additional 5 percent eould 
be removed by washing in 1 mM MgC1 2, Therefore, 75 percent of the 
steroid was tightly bound to the cell wall with the remaining 25 
percent being somewhat more loosely bound. 
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~xperiments utilizing both sheep red blood cells and a. subtilis ,..... 
W23 pro top 1 as ts demonstrated that the hydroxypyra zo 1 e was membnrne 
active. This action at the membrane was somewhat gentle in nature in 
that it caused leakage rather than lysis of the membrane in contrast 
to the action of detergents and membrane active antibiotics, A period 
of 24 hours was necessary to release 30 percent of the hemoglobin 
from sheep red blood cells, and the optical density of B. subtilis 
~' 
W23 protoplasts did not decrease significantly until 6 hours after 
treatment with 20 µg/ml of the hydroxypyrazole, These results are in 
agreement with those of Smith, Shay and Doorenbos (1964) who reported 
that 50 percent of the sheep red blood cells remained intact after 16 
hours following treatment with a nitrogen~substituted cholestane. 
Experiments concerning the effect of the hydroxypyrazole on uptake 
of labeled substrates substantiated the theory that action at the 
membrane was gentle ·in nature, A generalized type of inhibition wq.s 
not observed, On the contrary, of the substrates tested only the 
uptake of 14c-uracil was shown to be affected by the hydt"loxypyra:z;ol e. 
Therefore, uptake inhibition was specific and not indicative of an 
extensive disorganization of the cell membrane. 
Further investigation indicated that the hydroxypyrazole compound 
was also active at the DNA level. Experiments utilizing B. subtilis 
-: . 
168, an indoleless strain, indicated that reversion to indole positive 
was 8 times higher in cells grown in the presence of the hydroxypyra-
zole as compared to a control. Thermal melting experiments using DNA 
isolated from P. fluorescens showed a shift to higher melting tempera-
tures in the presence of the hydroxypyrazole which is indicative of 
binding to DNA. Further evidence for binding of the hydroxypyra~ole 
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to DNA WQS indicated by acldition of calf thymus DNA to the compound, 
The UV absorption peaks of the hydroxypyrazole at 300 and 312 nm wer~ 
decreased by at least 30 percent which indicated that the compound was 
binding to DNA. These observations are in agreement with the work of 
Mahler and Baylor (1967) who postulated that the primary site of 
action of the azasteroid, IDA, was at the DNA level, Krey and Hahn 
(1969) observed a decrease in the UV absorbance peaks of berberine, 
similar to that obs~rved with the hydroxypyrazole, when calf thymus 
DNA was added to a solution of the compound. 
The site of binding of the hydroxypyrazole on the DNA molecule 
was not definitely determined; however, UV absorption data indicated 
that the compound may bind to guanine. Mixing of the hydroxypyrazole 
and GMP under acid conditions produced a slight change in the UV 
spectrum of GMP which was visible to a lesser extent at neutral pH. 
Experiments involving the use of the hydroxypyrazole in combina-
tion with various antibiotics indicated that potentiation of antibiot-
ic action was present with two membrane active antibiotics, polymyxin 
and circulin, and also with actinomycin D. UV absorption spectra of 
the hydroxypyrazole and actinomycin D indicated that the two com-
pounds form a complex. An additional absorption peak at 270 nm in 
the actinomycin D UV absorption spectrum was observed when the 
hydroxypyrazole was added. Addition of either DMSO or DMF, two 
hydrogen bond breaking agents, either prevented formation of the 
complex or shifted the UV spectrum back to normal after cornp1ex 
formation. This evidence was substantiated by UV fluorescence 
experiments which indicated that actinomycin D would quench the 
fluorescent spectrum of the hydroxypyraz;o 1 e, As with the UV absorp-
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tion experiments, addition of DMSO prevented the quenching phenomenon. 
Calorimetry studies indicated that the heat of formation of the complex 
was slightly exothermic. 
Tissue culture experiments using KB and LM cell strains indicated 
that the effect of the hydroxypyrazole was small at the concentrations 
used to inhibit bacterial cells. Whole animal experiments using 
female mice indicated that the compound had no estrogenic properties 
• and produced no toxic effect in treated animals, 
Therefore, it is proposed that the hydroxypyraz~le compound has 
at least two sites of action~-one at the membrane and the other at the 
DNA level, Potentiation experiments with membrane act1v~ antibiotics 
indicate that the compound may have therap(;)utic va1ue in.treatment of 
Pseudomonas and related infections. Potentiation of actinornycin D 
action also demonstrates a potential use of the hydroxypyrazole as an 
aid in the treatment of cancer. It is plausible that much lower 
concentrations of actinomycin D would be necessary for treatment when 
used in combination with the hydroxypyrazole. Complex formation 
between the hydroxypyrazole and actinomycin D could allow quicker 
passage of actinomycin D through the membrane by virtue of the membrane 
action of the hydroxypyrazole. The fact that the hydroxypyrazole 
possesses no estrogenic act'ivity and produces no toxic effect in whole 
animals further emphasizes its potential as a therapeutic agent. 
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